Vident Investment Advisory »

Crispr Therapeutics shares owned by Vident Investment Advisory

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Vident Investment Advisory from 13F filings

Historical chart of Vident Investment Advisory investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Vident Investment Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Vident Investment Advisory

Quarter filed Position value Share count Share price at filing
2023-06-30 $491k 8.7k 56.14
2023-03-31 $1.1M 24k 45.23
2022-12-31 $869k 21k 40.65
2022-09-30 $763k 15k 50.23
2022-06-30 $769k 13k 60.58
2022-03-31 $1.1M 17k 62.77
2021-12-31 $1.1M 15k 75.81
2021-09-30 $1.4M 13k 111.95
2021-06-30 $2.3M 14k 161.89
2021-03-31 $1.4M 12k 121.86
2020-12-31 $1.8M 12k 153.08
2020-09-30 $1.8M 22k 83.65
2020-06-30 $1.7M 23k 73.48
2020-03-31 $981k 23k 42.68
2019-12-31 $1.4M 24k 60.92
2019-09-30 $1.3M 32k 40.98
2019-06-30 $1.5M 33k 47.09

More positions owned by Vident Investment Advisory